Your browser doesn't support javascript.
loading
Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review.
Isaka, Yuri; Sasaki, Akinori; Saito, Akira; Motomura, Yasuaki; Ando, Yayoi; Nakamura, Yoshiaki.
Afiliación
  • Isaka Y; Department of Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Sasaki A; Department of Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Saito A; Department of Pathology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Motomura Y; Department of Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
  • Ando Y; Clinical Research Support Office, National Cancer Center Hospital Chuou, Tokyo, Japan.
  • Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Front Oncol ; 12: 1064944, 2022.
Article en En | MEDLINE | ID: mdl-36713517
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón